Serum levels of angiogenin, basic fibrob
β
Nils Glenjen; Knut Anders Mosevoll; Γystein Bruserud
π
Article
π
2002
π
John Wiley and Sons
π
French
β 204 KB
Angiogenesis seems to be important both in the pathogenesis of acute myelogenous leukemia (AML) and for the susceptibility of AML blasts to chemotherapy. Recent clinical studies even suggest that antiangiogenic therapy can induce disease control in patients with AML relapse. In this context we have